By Brian Mudge and Andrew Kasnevich (August 8, 2017, 1:06 PM EDT) -- Covered business method reviews are an important component of America Invents Act patent trials, but the extent of patents eligible for CBM review has not been subject to a consistent standard. In the first part of this article, we discussed the Federal Circuit's decisions narrowing the scope of CBM eligibility, eliminating from CBM review patents claiming activities that are only "incidental to" or "complementary to" financial activity, and its most recent order denying en banc rehearing in Secure Axcess — which may have settled the legal question of CBM scope. In the final part, we discuss recent Patent Trial and Appeal Board decisions showing how the board has adjusted its approach in evaluating whether a patent is eligible for CBM review in view of the Federal Circuit's guidance, along with considerations for parties and practitioners going forward....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
